Clinical trial
Study Evaluating Antibiotic Utilization Measures and Control of…
NCT00254696 · Wyeth is now a wholly owned subsidiary of Pfizer, Industry · Completed
Key facts
| NCT number | NCT00254696 |
|---|---|
| Title | Study Evaluating Antibiotic Utilization Measures and Control of Extended-Spectrum-Lactamases (ESBLs) |
| Official title | Association of Antibiotic Utilization Measures and Control of Extended-spectrum-lactamases (ESBLs) |
| Lead sponsor | Wyeth is now a wholly owned subsidiary of Pfizer, Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Bacterial Infection |
| Intervention type | Drug |
| Interventions | Extended-Spectrum-Lactamases (ESBLs) |
| Enrollment | 710 |
| Start date | Jun 1, 2004 |
| Primary completion | Mar 1, 2005 |
| Completion | Mar 1, 2005 |
| First posted | Nov 16, 2005 |
| Last update posted | Apr 15, 2011 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: